No Detail Found!

Effect of fluorouracil and plastic breast-conserving surgery in young patients with early breast cancer

Author(s)
Feng Wu Department of Day Operation Treatment, Cangzhou Central Hospital,Cangzhou, Hebei,China
Xiaoyu Zhang Thyroid Breast External Three Departments, Cangzhou Central Hospital,Cangzhou, Hebei,China
Abstract
To explore the effect of fluorouracil and plastic breast-conserving surgery on the immune level, psychological status and quality of life of young patients with early breast cancer. Seventy-six young patients with early breast cancer admitted to Cangzhou Central Hospital from January 2016 to January 2017 were selected and divided into a control group (n=38, conventional breast-conserving surgery) and an observation group (n=38, Fluorouracil and plastic breastconserving surgery). The observation group had shorter operation time and hospital stay and less intraoperative blood loss in comparison to the control group (P<0.05); the CD4+, CD8+ and IL-8 of the observation group were higher, and the CD4+/CD8+ and IL-10 were lower (P<0.05); the HAMD and HAMA scores of the observation group were significantly lower (P<0.05); the physiological, emotional, and family, functional, and additional concerns were lower in the observation group (P<0.05); the postoperative breast shape satisfaction was higher in the observation group (P<0.05). Fluorouracil combined with plastic breast-conserving surgery has a better treatment effect on young patients with early breast cancer, which can promote postoperative recovery, maintain normal breast morphology, reduce the immune function damage caused by the surgery, improve patients' psychological status and quality of life, and reduce the incidence of postoperative complications and deaths.
Publication Details
Page(s) 2365-2370
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP6, Year: 2021

Request the full text from PASTIC

Keywords
Quality of life, Plastic breast-conserving surgery, immune level, early breast cancer, Mental state
References
Cameron D,Piccart-Gebhart MJ,Gelber RD,Procter M,Goldhirsch A,de Azambuja E,Castro G,Untch M,Smith I,Gianni L,Baselga J,Al-Sakaff N,Lauer S,McFadden E,Leyland-Jones B,Bell R,Dowsett M,Jackisch C,Adjuvant (HERA) Trial Study Team C .2017 .11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial. , 389(10075) : 1195-1205.
Chan SW,Cheng PS,Lam SH .2010 .Cosemrtic uotcome and percentage of breast volome excision in oncoplastic breast conserving surgely. World J. Sury, 34(7) : 1447-1452.
Dahlback C,Ringberg A,Manjer J .2019 .Aesthetic outcome following breast-conserving surgery assessed by three evaluation modalities in relation to healthrelated quality of life. Br. J. Surg., 106(1) : 90-99.
De La Cruz L,Blankenship SA,Chatterjee A,Geha R,Nocera N,Czerniecki BJ,Tchou J,Fisher CS .2016 .Outcomes After oncoplastic Breast-conserving surgery in breast cancer patients: A systematic literature review. Ann. Surg, 23(10) : 1-12.
De Lorenzi F,Hubner G,Rotmensz N,Bagnardi V,Loschi P,Maisonneuve P,Venturino M,Orecchia R,Galimberti V,Veronesi P,Rietjens M .2016 .Oncological results of oncoplastic breast-conserving surgery: Long term follow-up of a large series at a single institution: A matched-cohort analysis. Eur. J. Surg, 42(1) : 7177.
De Lorenzi F,Loschi P,Bagnardi V,Rotmensz N,Hubner G,Mazzarol G,Orecchia R,Galimberti V,Veronesi P,Colleoni MA,Toesca A,Peradze N,Mario R .2016 .Oncoplastic breast-conserving surgery for tumors larger than 2 centimeters: Is it oncologically safe a matched-cohort analysis. Ann. Surg, 23(6) : 1852-1859.
Du J,Yu Q,Xiao ML .2019 .The efficacy of docetaxel combined with oxaliplatin and 5-fluorouracil in the treatment of advanced gastric cancer. Chin. J. Clin. Oncol. Rehab, 26(03) : 44-46.
El-Sabawi B,Sosin M,Carey JN,Nahabedian MY,Patel KM .2015 .Breast reconstruction and adjuvant therapy: A systematic review of surgical outcomes. J. Surg, 112(5) : 458-464.
Kawano T,Miyakoshi N,Suzuki T,Kasukawa Y,Ishikawa N,Tazawa H,Yumoto S,Tani T,Enomoto K,Shimada Y .2016 .Chronic expanding hematoma resulting from osteoporotic insufficiency fracture of the pubis. J. Orthop. Sci., 21(6) : 865-869.
Kim JY,Jung SY,Lee S,Kang HS,Lee ES,Park IH,Lee KS,Ro J,Lee NK,Shin KH .2016 .Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in earlystage breast cancer. Int. J. Radia. Oncol. Biol. Phys., 87(5) : 1037-1042.
Langhans L,Jensen MB,Talman MM,Vejborg I,Kroman N,Tvedskov TF .2016 .Reoperation rates in ductal carcinoma in situ vs invasive breast cancer after Wireguided Breast-conserving surgery. JAMA Surg, 152(4) : 378.
Morrow M,Van Zee KJ,Solin LJ,Houssami N,ChavezMacGregor M,Harris JR,Horton J,Hwang S,Johnson PL,Marinovich ML,Schnitt SJ,Wapnir I,Moran MS,Clin MS .2016 .Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma. , 34(33) : 4040-4046.
Murata A,Sannomiya N,Miyamoto N,Ueda N,Kamida A,Koyanagi Y,Nagira H,Matsuda E,Hashimoto Y,Sato K,Hirooka Y,Hosoya K,Takagi Y,Tanaka Y,Araki K,Ishiguro K,Hirooka Y .2015 .Microcalcification of tumor is a predictor of response to neoadjuvant chemotherapy for invasive breast carcinoma. Yonago Acta Med, 58(2) : 85-88.
Naqvi A A,Zehra F,Ahmad R and Ahmad N F .2016 .Developing a research instrument to document awareness, knowledge, and attitudes regarding breast cancer and early detection techniques for Pakistani women: The Breast Cancer Inventory (BCI). Diseases, 4(4) : 37-41.
O'Brien JA,Ho A,Wright GP,Stempel M,Patil S,Krause K,Morrow M,Gemignani ML .2015 .Breastconserving surgery in bilateral breast cancer. Ann Surg Oncol, 22(10) : 3389-3396.
Rajan SS,Sharma SC,Kumar N,Kumar R,Singh G,Singh R,Tomar P .2014 .Clinical and cosmetic results of breast boost radiotherapy in early breast cancer: A randomized study between electron and photon. J. Cancer Res. Ther., 10(4) : 889-895.
Rosenberger LH,Mamtani A,Fuzesi S,Stempel M,Eaton A,Morrow M,Gemignani ML .2016 .Early adoption of the SSO-ASTRO consensus guidelines on margins for Breast-conserving surgery with wholebreast irradiation in stage Ⅰ and Ⅱ invasive breast cancer: Initial experience from memorial sloan kettering cancer center. Ann. Surg, 23(10) : 3239-3246.
Sherwell-Cabello S,Maffuz-Aziz A,Villegas-Carlos F,Domínguez-Reyes C,Labastida-Almendaro S,Rodríguez-Cuevas S .2015 .Feasibility and cosmetic outcome of oncoplastic surgery in breast cancer treatment. Cir Cir, 83(3) : 199-205.
Soltani S,Mokarian F,Panjehpour M .2015 .The expression of CK-19gene in circulating tumor cells of blood samples of metastatic breast cancer women. Res. Pharm. Sci., 10(6) : 485-496.
Strnad V,Ott OJ,Hildebrandt G,Kauer-Dorner D,Knauerhase H,Major T,Lyczek J,Guinot JL,Dunst J,Gutierrez Miguelez C,Slampa P,Allgäuer M,Lössl K,Polat B,Kovács G,Fischedick AR,Wendt TG,Fietkau R,Hindemith M,Resch A,Kulik A,Arribas L,Niehoff P,Guedea F,Schlamann A,Pötter R,Gall C,Malzer M,Uter W,Polgár C,Oncology (GEC-ESTRO) C .2016 .5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast:a randomised, phase 3, non-inferiority trial. Lancet, 387(10015) : 229-238.
Chia S Sun J .2016 .Adjuvant chemotherapy and HER-2-directed therapy for early-stage breast cancer in the elderly. Br. J. Cancer, 116(1) : 4-9.
Wu PH,Xu L PH .2019 .Research progress in the relationship between the expression levels of DPD, MTHFR and TS and the efficacy and prognosis of fluorouracils in the treatment of gastrointestinal tumors. Modern Oncol. Med, 027(012) : 2192-2195.
Xia L,Plachynta M,Liu T,Xiao X,Song J,Li X,Zhang M,Yao Y,Luo H,Hao X,Ben-David Y .2016 .Proinflammatory effect of a traditional Chinese medicine formula with potent anti-cancer activity in vitroimpedes tumor inhibitory potential in vivo. Mol. Clin. Oncol., 5(6) : 717-723.
Yu JZ,Pan PF,Zhang H PF .2019 .The efficacy of methotrexate combined with 5-fluorouracil in the treatment of malignant trophoblastic tumors. Chin. J. Clin. Oncol. Rehab, 26(5) : 529-531.
0

Citations

0

Downloads

10

Views